Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent and Refractory B-cell Non-Hodgkin's Lymphoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01995669
What this trial is testing

Lenalidomide and Obinutuzumab in Treating Patients With Relapsed Indolent Non-Hodgkin Lymphoma

Who this might be right for
Grade 3a Follicular LymphomaRecurrent Follicular LymphomaRecurrent Grade 1 Follicular Lymphoma+7 more
M.D. Anderson Cancer Center 66
Testing effectiveness (Phase 2)Ended earlyNCT03037645
What this trial is testing

Safety, PK, PD, and Antitumor Activity of Vecabrutinib (SNS-062) in B Lymphoid Cancers

Who this might be right for
Chronic Lymphocytic LeukemiaSmall Lymphocytic LymphomaLymphoplasmacytoid Lymphoma+5 more
Sunesis Pharmaceuticals 39
Testing effectiveness (Phase 2)UnknownNCT02652910
What this trial is testing

Memory-enriched CAR-T Cells Immunotherapy for B Cell Lymphoma

Who this might be right for
Recurrent Adult Diffuse Large Cell LymphomaRecurrent Follicular LymphomaRecurrent Mantle Cell Lymphoma+6 more
Xinqiao Hospital of Chongqing 20
Early research (Phase 1)UnknownNCT03881774
What this trial is testing

Cord Blood Derived CAR-T Cells in Refractory/Relapsed B Cell Malignancies

Who this might be right for
RefractoryRelapsedB Cell Lymphoma+1 more
Henan Cancer Hospital 20
Testing effectiveness (Phase 2)Ended earlyNCT00005950
What this trial is testing

506U78 in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma or T-cell Lymphoma

Who this might be right for
Angioimmunoblastic T-cell LymphomaExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid TissueNodal Marginal Zone B-cell Lymphoma+7 more
National Cancer Institute (NCI) 111
Early research (Phase 1)Study completedNCT00003082
What this trial is testing

Monoclonal Antibody Therapy in Treating Patients With Advanced Cancer

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+4 more
University of Arizona 27
Large-scale testing (Phase 3)Study completedNCT00070382
What this trial is testing

Darbepoetin Alfa Compared With Epoetin Alfa in Treating Anemia in Patients Receiving Chemotherapy for Cancer

Who this might be right for
AnemiaLeukemiaLymphoma+4 more
Jonsson Comprehensive Cancer Center 14
Not applicableStudy completedNCT00014482
What this trial is testing

Music Therapy to Ease Pain and Emotional Distress in Patients With Hematologic Cancer Who Are Undergoing High-Dose Therapy and Stem Cell Transplantation

Who this might be right for
Anxiety DisorderChronic Myeloproliferative DisordersDepression+4 more
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)UnknownNCT06033820
What this trial is testing

Zanubrutinib+Lenalidomide+R-ICE in Relapsed/Refractory DLBCL

Who this might be right for
Diffuse Large B-cell Lymphoma RecurrentDiffuse Large B Cell Lymphoma Refractory
RenJi Hospital 20
Testing effectiveness (Phase 2)Study completedNCT03458260
What this trial is testing

Study of Pixantrone in CD20+ Relapsed/Refractory Aggressive Non-Hodgkin Lymphoma

Who this might be right for
Aggressive Non-Hodgkin Lymphoma
The Lymphoma Academic Research Organisation 74
Early research (Phase 1)UnknownNCT00009776
What this trial is testing

Monoclonal Antibody Therapy, Paclitaxel, and Cyclosporine in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
University of California, Davis
Early research (Phase 1)UnknownNCT04887025
What this trial is testing

Exploratory Study of a Novel Oncolytic Vaccinia Virus RGV004 in the Treatment of Refractory/Relapsed B-cell Lymphoma

Who this might be right for
Relapsed or Refractory B-cell Lymphoma
Second Affiliated Hospital, Zhejiang University, School of Medicine 25
Large-scale testing (Phase 3)Study completedNCT00005805
What this trial is testing

St. John's Wort in Relieving Fatigue in Patients Undergoing Chemotherapy or Hormone Therapy for Cancer

Who this might be right for
Chronic Myeloproliferative DisordersFatigueLeukemia+5 more
Memorial Sloan Kettering Cancer Center
Not applicableStudy completedNCT01053494
What this trial is testing

Massage Therapy Given by Caregiver in Treating Quality of Life of Young Patients Undergoing Treatment for Cancer

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAcute Undifferentiated LeukemiaAngioimmunoblastic T-cell Lymphoma+84 more
Wake Forest University Health Sciences 80
Testing effectiveness (Phase 2)Study completedNCT00002502
What this trial is testing

Combination Chemotherapy and Bone Marrow Transplantation in Treating Patients With Leukemia or Myelodysplastic Syndrome

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more
Memorial Sloan Kettering Cancer Center
Early research (Phase 1)Study completedNCT00003395
What this trial is testing

Arsenic Trioxide in Treating Patients With Advanced Hematologic Cancer

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Ended earlyNCT00848328
What this trial is testing

Lenalidomide and Rituximab in Treating Patients With Non-Hodgkin Lymphoma

Who this might be right for
Lymphoma
University of California, Davis 30
Early research (Phase 1)Looking for participantsNCT06703892
What this trial is testing

Evaluate the Safety and Clinical Activity of GF- CART01 (CD20/19 CAR T Cell) in Subjects With Relapsed or Refractory B-Cell Hematological Malignancies

Who this might be right for
Diffuse Large B Cell Lymphoma RelapsedDiffuse Large B Cell Lymphoma RefractoryFollicular Lymphoma ( FL)+3 more
GenomeFrontier Therapeutics TW Co., Ltd. 18
Testing effectiveness (Phase 2)Looking for participantsNCT06996132
What this trial is testing

Bispecific Antibody-Based Salvage Therapy Followed by CAR-T ± ASCT in R/R Aggressive B-Cell Lymphoma

Who this might be right for
Relapsed or Refractory Aggressive B-cell Lymphoma
Institute of Hematology & Blood Diseases Hospital, China 25
Testing effectiveness (Phase 2)Looking for participantsNCT06987916
What this trial is testing

Efficacy and Safety Evaluation of U01(ssCART-19) in B-Cell Lymphoma

Who this might be right for
B Cell Lymphoma
Shanghai Tongji Hospital, Tongji University School of Medicine 50
Next Page